Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Acreage Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.29 |
52 Week High | US$0.81 |
52 Week Low | US$0.14 |
Beta | 2.01 |
11 Month Change | -31.98% |
3 Month Change | -17.61% |
1 Year Change | 36.05% |
33 Year Change | -86.40% |
5 Year Change | n/a |
Change since IPO | -89.17% |
Recent News & Updates
Recent updates
Shareholder Returns
ACRG.B.U | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 2.6% | 3.6% | 1.2% |
1Y | 36.0% | 39.3% | 11.3% |
Return vs Industry: ACRG.B.U underperformed the Canadian Pharmaceuticals industry which returned 39.3% over the past year.
Return vs Market: ACRG.B.U exceeded the Canadian Market which returned 11.3% over the past year.
Price Volatility
ACRG.B.U volatility | |
---|---|
ACRG.B.U Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 13.0% |
Market Average Movement | 8.2% |
10% most volatile stocks in CA Market | 16.8% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ACRG.B.U's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ACRG.B.U's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 888 | Dennis Curran | www.acreageholdings.com |
Acreage Holdings, Inc. operates in cannabis industry in the United States. It cultivates and processes cannabis plants; manufactures branded consumer products; distributes cannabis flower and manufactured products; and retails dosable cannabis products to consumers. The company serves medical and adult recreational use customers in Connecticut, Illinois, Maine, Massachusetts, New Jersey, New York, Ohio, and Pennsylvania under the The Botanist, Prime, and Superflux brands.
Acreage Holdings, Inc. Fundamentals Summary
ACRG.B.U fundamental statistics | |
---|---|
Market cap | US$39.90m |
Earnings (TTM) | -US$82.48m |
Revenue (TTM) | US$212.72m |
0.1x
P/S Ratio-0.4x
P/E RatioIs ACRG.B.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ACRG.B.U income statement (TTM) | |
---|---|
Revenue | US$212.72m |
Cost of Revenue | US$155.15m |
Gross Profit | US$57.56m |
Other Expenses | US$140.04m |
Earnings | -US$82.48m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.71 |
Gross Margin | 27.06% |
Net Profit Margin | -38.77% |
Debt/Equity Ratio | -324.3% |
How did ACRG.B.U perform over the long term?
See historical performance and comparison